MicroRNA-135b and its circuitry networks as potential therapeutic targets in colon cancer

Frontiers in Oncology

Volumn 3 OCT, Issue , 2013, Pages

  Khatri, Rohini ^a   Subramanian, Subbaya ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Colon cancer; EGFR; MicroRNAs; MiR 135b; STAT3

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD33 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MICRORNA; MICRORNA 135B; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER STEM CELL; CELL DIVISION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; COLON CANCER; GEL MOBILITY SHIFT ASSAY; GENE MUTATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; IMMUNOFLUORESCENCE TEST; LUNG NON SMALL CELL CANCER; MICROARRAY ANALYSIS; NONHUMAN; OVERALL SURVIVAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84891079798     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00268     Document Type: Article

References (23)

1. Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N, et al. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer (2006) 5:29. doi: 10.1186/1476-4598-5-29
2. Lowery AJ, Miller N, Devaney A, Mcneill RE, Davoren PA, Lemetre C, et al. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res (2009) 11:R27. doi:10.1186/bcr2257
3. Tong AW, Fulgham P, Jay C, Chen P, Khalil I, Liu S, et al. MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther (2009) 16:206-16. doi:10.1038/cgt.2008.77
4. Lin CW, Chang YL, Chang YC, Lin JC, Chen CC, Pan SH, et al. MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the hippo pathway and LZTS1. Nat Commun (2013) 4:1877. doi:10.1038/ncomms2876
5. Avruch J, Zhou D, Fitamant J, Bardeesy N. Mst1/2 signalling to yap: gatekeeper for liver size and tumour development. Br J Cancer (2011) 104:24-32. doi:10.1038/sj.bjc.6606011
6. Zhang L, Sun ZJ, Bian Y, Kulkarni AB. MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma. Cancer Lett (2013) 331:230-8. doi:10.1016/j.canlet.2013.01.003
7. Nagel R, Le Sage C, Diosdado B, Van Der Waal M, Oude Vrielink JA, Bolijn A, et al. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res (2008) 68:5795-802. doi:10.1158/0008-5472.CAN-08-0951
8. Sarver AL, French AJ, Borralho PM, Thayanithy V, Oberg AL, Silverstein KA, et al. Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer (2009) 9:401. doi:10.1186/1471-2407-9-401
9. Yuki D, Lin YM, Fujii Y, Nakamura Y, Furukawa Y. Isolation of LEM domain-containing 1, a novel testis-specific gene expressed in colorectal cancers. Oncol Rep (2004) 12:275-80.
10. Lampropoulos P, Zizi-Sermpetzoglou A, Rizos S, Kostakis A, Nikiteas N, Papavassiliou AG. TGF-beta signalling in colon carcinogenesis. Cancer Lett (2012) 314:1-7. doi:10.1016/j.canlet.2011.09.041
11. Matsuyama H, Suzuki HI, Nishimori H, Noguchi M, Yao T, Komatsu N, et al. miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma. Blood (2011) 118:6881-92. doi:10.1182/blood-2011-05-354654
12. Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer (2009) 9:798-809. doi:10.1038/nrc2734
13. Yue P, Turkson J. Targeting STAT3 in cancer: how successful are we? Expert Opin Investig Drugs (2009) 18:45-56. doi:10.1517/13543780802565791
14. Corvinus FM, Orth C, Moriggl R, Tsareva SA, Wagner S, Pfitzner EB, et al. Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia (2005) 7:545-55. doi:10.1593/neo.04571
15. Baba Y, Fujii M, Tokumaru Y, Kato Y. Present and future of EGFR inhibitors for head and neck squamous cell cancer. J Oncol (2012) 2012:986725. doi:10.1155/2012/986725
16. Sen M, Joyce S, Panahandeh M, Li C, Thomas SM, Maxwell J, et al. Targeting Stat3 abrogates EGFR inhibitor resistance in cancer. Clin Cancer Res (2012) 18:4986-96. doi:10.1158/1078-0432.CCR-12-0792
17. Heinemann V, Stintzing S, Kirchner T, Boeck S, Jung A. Clinical relevance of EGFR-and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR. Cancer Treat Rev (2009) 35:262-71. doi:10.1016/j.ctrv.2008.11.005
18. Dobi E, Monnien F, Kim S, Ivanaj A, N'guyen T, Demarchi M, et al. Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer. Clin Colorectal Cancer (2013) 12:28-36. doi:10.1016/j.clcc.2012.09.002
19. Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, Vallabhapurapu S, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell (2009) 15:103-13. doi:10.1016/j.ccr.2009.01.001
20. Sansone P, Bromberg J. Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol (2012) 30:1005-14. doi:10.1200/JCO.2010.31.8907
21. Necela BM, Carr JM, Asmann YW, Thompson EA. Differential expression of microRNAs in tumors from chronically inflamed or genetic (APC(Min/+)) models of colon cancer. PLoS One (2011) 6:e18501. doi:10.1371/journal.pone.0018501
22. Sanchez-Diaz PC, Hsiao TH, Chang JC, Yue D, Tan MC, Chen HI, et al. De-regulated microRNAs in pediatric cancer stem cells target pathways involved in cell proliferation, cell cycle and development. PLoS One (2013) 8:e61622. doi:10.1371/journal.pone.0061622
23. Lin L, Liu A, Peng Z, Lin HJ, Li PK, Li C, et al. STAT3 is necessary for proliferation and survival in colon cancer-initiating cells. Cancer Res (2011) 71:7226-37. doi:10.1158/0008-5472.CAN-10-4660